Vol 6 (March 30, 2022): Annals of Nasopharynx Cancer

Review Article 
Plasma Epstein-Barr virus DNA analysis for personalised management of nasopharyngeal carcinoma—current opportunities and challenges
Wai Kei Jacky Lam, Yuk Ming Dennis Lo
Annals of Nasopharynx Cancer  
2022;
6:
4  
Review Article 
Epstein-Barr virus-based nasopharyngeal carcinoma population screening
Xia Yu, Honglin Chen, Mingfang Ji
Annals of Nasopharynx Cancer  
2022;
6:
3  
Review Article 
Prognostic value of Epstein-Barr virus biomarkers for nasopharyngeal carcinoma staging and post-treatment surveillance
Jacob A. Miller, Benjamin A. Pinsky, Quynh-Thu Le
Annals of Nasopharynx Cancer  
2022;
6:
2